Advertisement

ADVERTISEMENT

Multiple Myeloma

Conference Insider
Triplet Therapy Superior to Doublet for Patients With Lenalidomide-Refractory MM
12/02/2020
Data being presented at the virtual 62nd ASH Annual Meeting and Exposition show that triplet therapy is superior to doublet therapy for the treatment of lenalidomide-refractory MM.
Data being presented at the virtual 62nd ASH Annual Meeting and Exposition show that triplet therapy is superior to doublet therapy for the treatment of lenalidomide-refractory MM.
Data being presented at the...
12/02/2020
Oncology
Noopur Raje, MD, Talks Anti-BCMA CAR-T Therapy for Relapsed/Refractory MM
Podcasts
Noopur Raje, MD, Talks Anti-BCMA CAR-T Therapy for Relapsed/Refractory MM
10/28/2020
In this podcast, Dr Raje discusses the clinical significance of anti-BCMA CAR-T therapy with bb2121 in patients with relapsed or refractory MM.
In this podcast, Dr Raje discusses the clinical significance of anti-BCMA CAR-T therapy with bb2121 in patients with relapsed or refractory MM.
In this podcast, Dr Raje...
10/28/2020
Oncology
Conference Insider
Triplet Combo Yields Significant Efficacy in Certain Patients With Lenalidomide-Refractory MM
10/23/2020
A triplet combo therapy comprising carfilzomib, lenalidomide, and dexamethasone has shown significant efficacy in patients with relapsed or refractory MM.
A triplet combo therapy comprising carfilzomib, lenalidomide, and dexamethasone has shown significant efficacy in patients with relapsed or refractory MM.
A triplet combo therapy...
10/23/2020
Oncology
BCMA-Directed CAR-T Therapy Shows Promise in Pretreated MM
Podcasts
BCMA-Directed CAR-T Therapy Shows Promise in Pretreated MM
10/22/2020
Jesus Berdeja, MD, discusses the results of the CARTITUDE-1 trial exploring BCMA-directed CAR-T therapy in relapsed/refractory MM.
Jesus Berdeja, MD, discusses the results of the CARTITUDE-1 trial exploring BCMA-directed CAR-T therapy in relapsed/refractory MM.
Jesus Berdeja, MD, discusses the...
10/22/2020
Oncology
Navigating the MM Treatment Landscape
Podcasts
Navigating the MM Treatment Landscape
10/20/2020
Natalie S. Callander, MD, discusses individualized treatment approaches for patients with relapsed or refractory MM.
Natalie S. Callander, MD, discusses individualized treatment approaches for patients with relapsed or refractory MM.
Natalie S. Callander, MD,...
10/20/2020
Oncology
Conference Insider
Triplet Combo Regimen Yields Significant Clinical Benefit in Relapsed/Refractory MM
09/19/2020
Real-world study findings show that therapy with ixazomib plus lenalidomide and dexamethasone yields significant clinical benefits in patients with relapsed/refractory MM.
Real-world study findings show that therapy with ixazomib plus lenalidomide and dexamethasone yields significant clinical benefits in patients with relapsed/refractory MM.
Real-world study findings show...
09/19/2020
Oncology
Sagar Lonial, MD, Discusses the TOURMALINE-MM4 Study
Videos
Sagar Lonial, MD, Discusses the TOURMALINE-MM4 Study
08/01/2020
Dr Lonial discusses a study on ixazomib as post-induction maintenance therapy for transplant-ineligible, newly-diagnosed MM.
Dr Lonial discusses a study on ixazomib as post-induction maintenance therapy for transplant-ineligible, newly-diagnosed MM.
Dr Lonial discusses a study on...
08/01/2020
Oncology
Conference Insider
Better Therapies Leading to Improved Outcomes for Transplant-Ineligible Patients With MM
07/17/2020
At the Great Debates & Updates in Hematologic Malignancies, Jonathan Kaufman, MD, discussed the standard front-line treatment approach for transplant-ineligible MM.
At the Great Debates & Updates in Hematologic Malignancies, Jonathan Kaufman, MD, discussed the standard front-line treatment approach for transplant-ineligible MM.
At the Great Debates & Updates...
07/17/2020
Oncology
Tremendous Advances in Myeloma for 2020
Videos
Tremendous Advances in Myeloma for 2020
06/16/2020
Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Joseph Mikhael, MD, talks about...
06/16/2020
Oncology
Contemporary Topics in the Treatment of Hematologic Malignancies
Videos
Contemporary Topics in the Treatment of Hematologic Malignancies
06/13/2020
Agner Paner, MD, will address updates in supportive care for patients with multiple myeloma at the virtual 2020 Great Debates & Updates in Hematologic Malignancies.
Agner Paner, MD, will address updates in supportive care for patients with multiple myeloma at the virtual 2020 Great Debates & Updates in Hematologic Malignancies.
Agner Paner, MD, will address...
06/13/2020
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use